Exelixis (EXEL) Retained Earnings (2010 - 2026)
Exelixis (EXEL) recorded quarterly Retained Earnings of -$415000.0 in Q2 2026, down 111.94% quarter-over-quarter from $3.5 million in Q1 2026, and down 120.65% on a YoY basis from $2.0 million in Q2 2025.
Exelixis (EXEL) Retained Earnings (2010 - 2026) Analysis & Trends
Exelixis' Retained Earnings history runs 17 years deep, the most recent figure standing at -$415000.0 for Q2 2026.
- In Q2 2026, Retained Earnings fell 120.65% year-over-year to -$415000.0; the TTM figure through Apr 2026 stood at -$415000.0 (down 120.65% YoY), while the FY2026 annual figure was $3.5 million, up 358.05% from the prior year.
- Retained Earnings was -$415000.0 for Q2 2026 at Exelixis, down from $3.5 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $11.2 million in Q2 2023 to a low of -$258.9 million in Q1 2024.
- Historically, Retained Earnings has averaged -$52.0 million across 5 years, with a median of -$5.1 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Retained Earnings tumbled 5499.05% in 2022, then jumped 358.05% in 2026.
- A 5-year view of Retained Earnings shows it stood at -$14.5 million in 2022, then surged by 74.18% to -$3.8 million in 2023, then soared by 205.49% to $4.0 million in 2024, then tumbled by 2781.02% to -$106.1 million in 2025, then surged by 99.61% to -$415000.0 in 2026.
- The last three Retained Earnings figures came in at -$415000.0 (Q2 2026), $3.5 million (Q1 2026), and -$106.1 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -838.07 Mn |
| 10 | Exelixis | 13.71 Bn | 12.93 Bn | 590.86 Mn | -415,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -415,000.00 |
| Jan 2, 2026 | 3.48 Mn |
| Oct 3, 2025 | -106.06 Mn |
| Jul 4, 2025 | -219.54 Mn |
| Apr 4, 2025 | 2.01 Mn |
| Jan 3, 2025 | -1.35 Mn |
| Sep 27, 2024 | 3.96 Mn |
| Jun 28, 2024 | -5.15 Mn |
| Mar 29, 2024 | -258.95 Mn |
| Dec 29, 2023 | -3.75 Mn |
| Sep 29, 2023 | -126.05 Mn |
| Jun 30, 2023 | 11.19 Mn |
| Mar 31, 2023 | 5.80 Mn |
| Dec 30, 2022 | -14.52 Mn |
| Sep 30, 2022 | -17.54 Mn |
| Jul 1, 2022 | -8.92 Mn |
| Apr 1, 2022 | -147.93 Mn |
| Dec 31, 2021 | -216.51 Mn |
| Oct 1, 2021 | -311.67 Mn |
| Jul 2, 2021 | -349.88 Mn |